Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Dicerna Pharmaceuticals, Inc. (DRNA)

« Back to company index

DRNA Chatter Timeline

Stock Ticker for DRNA

Most Active Tweeters for DRNA

UserTweets
@Tickeron 5
@newsfilterio 4
@InsiderAlerts4U 3
@humour_humourrr 3
@MarcJacksonLA 3

Recent Tweets for DRNA

humour_humourrr @humour_humourrr
$DRNA CEO on Q1 ER call talked about another collaboration agreement coming which makes sense.There is no way they… https://t.co/W2VpPQRdTP
May 8th 2021, 5:05pm
SiteFocusHQ @SiteFocusHQ
$DRNA Earnings Intelligence Analysis of recent earnings identified Dicerna Pharmaceuticals, Inc (NASDAQ: DRNA ) bus… https://t.co/NB4L9FTueI
May 8th 2021, 12:05pm
SeekingAlpha @SeekingAlpha
$DRNA - Dicerna Pharmaceuticals (DRNA) CEO Doug Fambrough on Q1 2021 Results - Earnings Call Transcript.… https://t.co/48OuIxHovi
May 8th 2021, 12:05pm
newsfilterio @newsfilterio
Dicerna Announces First Quarter 2021 Financial Results and Provides a Business Update $DRNA https://t.co/ftInp0L3WZ
May 8th 2021, 7:05am
Tickeron @Tickeron
$DRNA in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/vzKQw4HK3X
May 7th 2021, 10:05pm
stb8444 @stb8444
removed $drna added $phio
May 7th 2021, 8:05pm
EarningsAlley @EarningsAlley
Dicerna Pharmaceuticals, Inc. $DRNA held an earnings call on 5/6/2021. Here are the highlights:
May 7th 2021, 8:05pm
MarcJacksonLA @MarcJacksonLA
$DRNA Chardan Capital Maintains Buy Rating On Dicerna Pharm, $34 PT https://t.co/PDrVYE6kuI
May 7th 2021, 2:05pm
newsfilterio @newsfilterio
Dicerna Pharmaceuticals EPS misses by $0.02, misses on revenue $DRNA https://t.co/il3K9zH8rZ
May 7th 2021, 5:05am
humour_humourrr @humour_humourrr
$DRNA I find it pretty interesting how revenues from collaborations remain underappreciated in biotech generally vs… https://t.co/JdO8wOo9Sk
May 7th 2021, 12:05am
EdgarInsider @EdgarInsider
A Form 8-K [Press/News Current Report] filing has been made with the SEC: $DRNA Dicerna Pharmaceuticals Inc https://t.co/2gwBFzAtsn
May 6th 2021, 11:05pm
ERCalendar @ERCalendar
Upcoming Earnings Report: $DRNA Dicerna Pharmaceuticals Reporting on 05/06/2021 at 4:00 PM? Get Free Daily ER Calen… https://t.co/J2KptLH7Ei
May 6th 2021, 10:05pm
wkissel @wkissel
$DRNA Dicerna posts 40% jump in Q1 revenue, gives cash position update https://t.co/yWUW93WRXJ
May 6th 2021, 10:05pm
StckPro @StckPro
$DRNA NEW ARTICLE : Dicerna posts 40% jump in Q1 revenue, gives cash position update https://t.co/kKJCl7lsx8 Get al… https://t.co/yk2H09j0lC
May 6th 2021, 9:05pm
newsfilterio @newsfilterio
Dicerna posts 40% jump in Q1 revenue, gives cash position update $DRNA https://t.co/mjCZHIcpOQ
May 6th 2021, 9:05pm
MarcJacksonLA @MarcJacksonLA
$DRNA Dicerna Announces 1Q 2021 Results & Corporate Update https://t.co/kCo8Rog2At
May 6th 2021, 9:05pm
EdgarInsider @EdgarInsider
SEC Form 10-Q [Quarterly Report] filed by $DRNA Dicerna Pharmaceuticals Inc https://t.co/n7ItTv00uE
May 6th 2021, 8:05pm
sbwcws @sbwcws
Dicerna sees cash sufficient to fund clinical, operating plan into 2024 $DRNA
May 6th 2021, 8:05pm
otcdynamics @otcdynamics
$DRNA Dicerna Announces First Quarter 2021 Financial Results and Provides a Business Update https://t.co/dZNJPOHW7l
May 6th 2021, 8:05pm
mediasentiment @mediasentiment
$DRNA new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 854
May 6th 2021, 8:05pm
glitchbotio @glitchbotio
RT @MarketCurrents: $DRNA - Dicerna Pharmaceuticals EPS misses by $0.02, misses on revenue https://t.co/HJwx7PdD9p
May 6th 2021, 8:05pm
MarketCurrents @MarketCurrents
$DRNA - Dicerna Pharmaceuticals EPS misses by $0.02, misses on revenue https://t.co/HJwx7PdD9p
May 6th 2021, 8:05pm
fintel_io @fintel_io
$DRNA / Dicerna Pharmaceuticals files form 8-K - Financial Statements and Exhibits, Results of Operations and Finan… https://t.co/xFFpd4RIEy
May 6th 2021, 8:05pm
StockPods @StockPods
$DRNA Earnings Call Today: 4:30 PM EST Webcast: https://t.co/nfBdCN8Zb1 Signup for the StockPods BETA now: https://t.co/Vma4E2hQ99
May 6th 2021, 7:05pm
AccesswireNews @AccesswireNews
$DRNA Dicerna Pharmaceuticals, Inc. to Host Earnings Call https://t.co/7PXEaDQzGf
May 6th 2021, 6:05pm
InsiderAlerts4U @InsiderAlerts4U
$DRNA: New Insider Filing on Dicerna Pharmaceuticals Inc's Chief Scientific Ofr., EVP R&D BOB D BROWN: https://t.co/fS1vY2sjUS
May 6th 2021, 2:05pm
Tickeron @Tickeron
Dicerna Pharmaceuticals Inc to report earnings on August 12, 2021. Earnings per share (EPS) estimate: $-0.39 $DRNA… https://t.co/MpvG4DO38v
May 5th 2021, 10:05pm
InsiderAlerts4U @InsiderAlerts4U
$DRNA: New Insider Filing on Dicerna Pharmaceuticals Inc's Chief Human Resources Officer REGINA M. PAGLIA: https://t.co/3XzFEjykcd
May 5th 2021, 9:05pm
ERCalendar @ERCalendar
Upcoming Earnings Report: $DRNA Dicerna Pharmaceuticals Reporting on 05/06/2021 at 4:00 PM? Get Free Daily ER Calen… https://t.co/0UmOByM1gP
May 5th 2021, 7:05pm
insiderbuyings @insiderbuyings
$DRNA new insider selling: 20000 shares. https://t.co/ekM2hv6N69
May 4th 2021, 6:05am
InsiderAlerts4U @InsiderAlerts4U
$DRNA: New Insider Filing on Dicerna Pharmaceuticals Inc's Chief Scientific Ofr., EVP R&D BOB D BROWN: https://t.co/4jYNLmUzx1
May 3rd 2021, 10:05pm
mehabecapital @mehabecapital
Insider Activity seen in $DRNA, Brown Bob D (Chief Scientifi) Option Exercise, Total-Shares = 10,000, Transaction… https://t.co/YrvntZi8hx
May 3rd 2021, 9:05pm
formwhisperscom @formwhisperscom
#FWSells $DRNA Brown Bob D, Chief Scientific Ofr., EVP R&D of Dicerna Pharmaceuticals Inc sold 20,000 shares on 202… https://t.co/EMU6j2lVUH
May 3rd 2021, 9:05pm
MarkC53916729 @MarkC53916729
@bigpharmaguy @lblegend33 No as much for $LLY as they have the most significant $DRNA partnership agreement. It wou… https://t.co/nnxPYB4Bz3
May 3rd 2021, 8:05pm
bigpharmaguy @bigpharmaguy
@MarkC53916729 @lblegend33 $DRNA M&A thesis is quite difficult.
May 3rd 2021, 8:05pm
MarkC53916729 @MarkC53916729
@lblegend33 They could buy Dicerna with that 5 billion $DRNA And eventually get a much much greater return
May 3rd 2021, 8:05pm
Tickeron @Tickeron
$DRNA's price moved above its 50-day Moving Average on April 13, 2021. View odds for this and other indicators:… https://t.co/tF4mzi7gdl
May 1st 2021, 7:05pm
Tickeron @Tickeron
$DRNA's price moved above its 50-day Moving Average on April 13, 2021. View odds for this and other indicators:… https://t.co/rYlIVOQPNy
April 30th 2021, 7:04pm
funstocks1 @funstocks1
$DRNA next target 42 https://t.co/14tOkFCUR4
April 30th 2021, 4:04pm
humour_humourrr @humour_humourrr
$DRNA I don't know what you see, but I see blue sky ahead ? https://t.co/1OBJcXMfOn
April 30th 2021, 3:04pm
newsfilterio @newsfilterio
Dicerna to Report First Quarter 2021 Financial Results on May 6, 2021 $DRNA https://t.co/d97uY5rg6h
April 30th 2021, 5:04am
otcdynamics @otcdynamics
$DRNA Dicerna to Report First Quarter 2021 Financial Results on May 6, 2021 https://t.co/G7zl8kuy1n
April 29th 2021, 8:04pm
FlashAlert_me @FlashAlert_me
$DRNA [15s. delayed]: Issued Press Release on April 29, 16:05:00: Dicerna to Report First Quarter 2021 Financial Re… https://t.co/yJhoObjn9F
April 29th 2021, 8:04pm
stock_titan @stock_titan
$DRNA Dicerna to Report First Quarter 2021 Financial Results on May 6, 2021 https://t.co/hmruyyuzjL
April 29th 2021, 8:04pm
TradeWithAlerts @TradeWithAlerts
Nice Print for $DRNA - Amount: $4,501,526.38 - to learn more, SIGNUP https://t.co/JWvlYbdLod or get a training https://t.co/0L4k6hWHAt!
April 28th 2021, 9:04pm
Jon12508683 @Jon12508683
$drna weekly candle looks constructive
April 28th 2021, 7:04pm
mikegoodma @mikegoodma
$DRNA has initiated PHYOX4 trial for PH3, a single-dose study in 6 patients. Data anticipated mid 2021. $DRNA's pla… https://t.co/b11av3jlKn
April 28th 2021, 2:04pm
happyycamperr @happyycamperr
$DRNA If it closes over 30, only second time in 7 years! lol
April 27th 2021, 7:04pm
Tickeron @Tickeron
$DRNA in Downtrend: Stochastic indicator peaks and leaves overbought zone. View odds for this and other indicators:… https://t.co/Z6sCjhTLIL
April 27th 2021, 10:04am
MarcJacksonLA @MarcJacksonLA
$DRNA Dicerna Pharmaceuticals Receives Average Rating of "Buy" from Analysts | $40.44 Average… https://t.co/IBGSaS2Xw6
April 26th 2021, 3:04pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.